
==== Front
Indian J Microbiol
Indian J Microbiol
Indian Journal of Microbiology
0046-8991
0973-7715
Springer India New Delhi

1218
10.1007/s12088-024-01218-5
Short Communications
The Pathology of the Brain Eating Amoeba Naegleria fowleri
http://orcid.org/0000-0001-9368-6985
Borkens Yannick yannick.borkens@charite.de

12
1 grid.6363.0 0000 0001 2218 4662 Institut für Pathologie, Charité Campus Mitte, Virchowweg 15, Charité, 10117 Berlin, Germany
2 https://ror.org/01hcx6992 grid.7468.d 0000 0001 2248 7639 Humboldt-Universität zu Berlin, Unter den Linden 6, 10117 Berlin, Germany
6 3 2024
6 3 2024
9 2024
64 3 13841394
1 10 2023
2 2 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The genus Naegleria is a taxonomic subfamily consisting of 47 free-living amoebae. The genus can be found in warm aqueous or soil habitats worldwide. The species Naegleria fowleri is probably the best-known species of this genus. As a facultative parasite, the protist is not dependent on hosts to complete its life cycle. However, it can infect humans by entering the nose during water contact, such as swimming, and travel along the olfactory nerve to the brain. There it causes a purulent meningitis (primary amoebic meningoencephalitis or PAME). Symptoms are severe and death usually occurs within the first week. PAME is a frightening infectious disease for which there is neither a proven cure nor a vaccine. In order to contain the disease and give patients any chance to survival, action must be taken quickly. A rapid diagnosis is therefore crucial. PAME is diagnosed by the detection of amoebae in the liquor and later in the cerebrospinal fluid. For this purpose, CSF samples are cultured and stained and finally examined microscopically. Molecular techniques such as PCR or ELISA support the microscopic analysis and secure the diagnosis.

Keywords

Amoebic
Nasal infections
Parasites
Protozoa
Tropical medicine
Charité - Universitätsmedizin Berlin (3093)Open Access funding enabled and organized by Projekt DEAL.

issue-copyright-statement© Association of Microbiologists of India 2024
==== Body
pmcInfectious diseases continue to be a major cause of illness and death, especially in poorer countries of the global South [1]. The pathogens that cause these diseases are diverse and rich in form. Alongside viruses and bacteria, parasites represent the third major pathogen caste of disease-causing agents [2]. Parasites occur, for example, in the form of intestinal worms or unicellular eukaryotes, so-called protists. Many dangerous and relevant diseases are caused by such protists. For example malaria, sleeping sickness, or Chagas disease. Many are dangerous tropical diseases that are relevant to travellers of the temperate countries of the global west [3] (Fig. 1).Fig. 1 Naegleria fowleri

The systematic classification of the protists is unclear and is subject to regular changes and adaptations. It is clear that protists are not a systematic clade in the strict sense [4, 5]. In some cases, they are referred to as algae [6]. Due to this diversity of forms, a meaningful classification that is relevant for targeted science is not easy. One possible classification focuses on the type of movement. Different protists have evolved different modes of locomotion: with cirripedes, cilia, flagella or as amoebae with pseudopodia [7]. Since the classification, like other types of protist characterization, focuses purely on external features and morphologies, there is no relationship within these classifications. Pathogens can be found in all of these classifications. For example, the causative agents of sleeping sickness and Chagas disease are distinguished by their characteristic flagella [8] (Fig. 2).Fig. 2 Simplified phylogenetic tree according to the 6-kingdom model of Woese et al. [109]. The cross-branches represent endosymbiosis events

This article deals with a different group of protists: the amoebae. Although amoebae may also cause dangerous diseases, they are overshadowed by other protist infections such as malaria, toxoplasmosis or Chagas disease.

Amoebae are also not a systematic clade, but a life form. Amoebae are unicellular organisms without a fixed body shape that are not closely related to each other. They move by the formation of so-called pseudopods. In doing so, the amoebae change their body shape [9]. At up to 1 mm, they belong to the largest protists. Some groups are shelled (Thecamoebae), but most are naked [10]. Amoebae feed heterotrophically via phagocytosis or autotrophically via photosynthesis. For this purpose, the autotrophic amoebae possess chloroplasts [11].

Amoebae are be found worldwide, including the Arctic and Antarctic [12]. Amoebae can also survive in airless space. For this purpose, they form cysts. However, most amoebae prefer moist soils and mud as well as water (fresh and salt water) [13]. The life form of the amoeba has evolved independently several times in evolutionary terms. In modern systematics, heterotrophic amoebae are usually classified as Amoebozoa, Rhizaria, and Excavata. Autotrophic forms usually belong to the group Chromalveolata [14, 15].

Many amoebae are pathogens for humans and can sometimes cause serious illnesses. One of the best known is probably amoebic dysentery. This is a severe gastrointestinal disease that causes, among other things, bloody, slimy diarrhea [16, 17]. Amoebic dysentery is caused by the entamoeba Entamoebe histolytica [18]. With approximately 50 million cases per year, amoebic dysentery is one of the most common protozoan infections [19–21]. Acanthamoebae can lead to severe inflammation of the cornea, especially in contact lens wearers [22]. For this reason, contact lenses should be cleaned regularly and the contact lens solution should also be changed regularly. Acanthamoeba keratitis is easy recognized and treat [23]. Amoebae can also cause inflammation in the oral cavity. Entamoeba gingivalis usually occurs in persistent gingivitis [24, 25]. In addition, amoebae can also serve as reservoir for pathogenic bacteria [26].

Much rarer than amoebic dysentery, but also much more extreme, is the so-called PAME. PAME stands for primary amoebic meningoencephalitis, a purulent inflammation of the brain. The associated pathogen is Naegleria fowleri [27].

Naegleria fowleri is a species of the genus Naegleria, which includes about 50 species. Naegleria belongs to the Tetramitia, the largest group of Heterolobosea, which groups together amoeboid protozoa. The Heterolobosea belong to the Excavata, one of the three eukaryotic supergroups [28, 29]. In this context, the Excavata are the only supergroup that is exclusively unicellular [30]. The remaining two, the Diaphoretickes and the Amorphea contain both unicellular and multicellular organisms. The Diaphoretickes include plants [31]. The Amorphea include fungi and animals [32]. The Excavata are divided into 7 groups without systematic rank: the Fornicata, the Malawimonas, the Parabasalia, the Preaxostyla, the Jakobida, the Euglenozoa and the Heterolobosea [30]. Species of the genus Naegleria are dependent on moisture and thus are found in moist soil as well as in stagnant water [33]. As it can spread optimally in warm waters, it can be found in swimming pools, bathing lakes and industrial wastewater [34]. Its distribution is not regionally limited. N. fowleri has been detected worldwide. Focal populations are found in the USA, Australia and France [35, 36]. Under ideal conditions, the trophozoites of N. fowleri form large colonies [37]. The trophozoite represents the amoeboid form. As a trophozoite, N. fowleri forms pseudopodia and feeds on bacteria and detritus. However, if the environmental parameters change, for example due to a drop in electrolyte levels, the cell forms flagella in order to escape quickly. If the parameters deteriorate further or escape is not possible, N. fowleri forms cysts. This cyst form is the smallest form with a size of up to 15 µm. The trophozoite is twice as large at 30 µm [38]. Figure 3 shows the different stages of the amoeba's life cycle.Fig. 3 Forms of Naegleria fowleri. Left: Cyst; middle: Trophozoite; right: Flagellate

Naegleria fowleri is a so-called facultative parasite. This means that, unlike other parasites, the amoeba does not require a host for its life cycle. Like other Naegleria species, N. fowleri reproduces via mitosis [36].

Naegleria is interesting from a molecular point of view. This is because the cell is capable of transforming from an amoeboid form without a cytoskeleton to a flagellate form with complex cytoskeletal structures and flagella. The mechanism is the subject of research. Naegleria gruberi has been established as a model in this respect. Although N. gruberi is very closely related to N. fowleri, it is not a pathogen and thus its safe for researchers [39, 40]. N. gruberi is the only Naegleria species whose genome has been completely sequenced. Medicine could also benefit from this research. For example, the conversion from the amoeboid type to the flagellate type or the associated mechanism (including the de novo synthesis of centrioles) could be a theoretical target of therapeutics [41–43]. In practice, however, this is considerably complicated by the status of N. fowleri or PAME as a neglected disease [35]. In general, there is no therapeutic need for this disease, although indescribably tragic for the individual patient. The reason for this is the rarity of the cases.

Route of infection

As already described, N. fowleri is a facultative parasite. This means that, unlike other protozoa such as Plasmodium spp. or Toxoplasma gondii, N. fowleri is not dependent on humans as hosts to complete its life cycle and thus reproduce [36, 44, 45]. Nevertheless, N. fowleri is capable of infecting humans and causing severe disease. In this case, infection occurs exclusively through the nose. If contaminated water is drawn up the nose, for example, during diving or when the head is held under water, N. fowleri cells can enter the brain via the olfactory nerve (Nervus olfactorius) [27, 36, 40]. Sources of infection are contaminated water sources such as lakes or swimming pools [37, 44] (see Fig. 4). Infections at home are also described less frequently. For example, via contaminated tap water [46, 47] or nasal rinsing [48]. This may also play a role in religious cleansing rituals [49, 50].

N. fowleri cannot be ingested via the oral route. Ingestion of contaminated water is therefore not dangerous [51, 52]. Infections via water vapor or droplets have also not been reported [53, 54]. As N. fowleri is very resistant, treatment of water, for example, with chlorine, is only of limited help [55]. However, wearing nose clips while swimming can significantly reduce the risk [56, 57]. Transmission between humans is not possible. This includes organ transplants. These have been discussed as a possible route of transmission for some time. However, transmission through transplantation has not been confirmed [58, 59] (Fig. 5).Fig. 4 Warning sign from the United States. Alachua County, Florida

Fig. 5 Life cycle of Naegleria fowleri. ©Centers for disease control and prevention, all rights reserved

Disease and Symptoms

If N. fowleri reaches the brain, the parasite causes a purulent meningitis. This meningitis is referred to in the clinic and in the literature as either primary amoebic meningoencephalitis (PAME or PAM), Naegleriasis or swimming pool amoebosis. The first symptoms usually appear between three and seven, but not later than 14 days, after exposure [45, 54]. The onset of symptoms is immediately and severe. At the beginning of the disease phase, PAME is characterized by severe nausea with vomiting, high fever, headache, and neck stiffness [60, 61]. The second phase is characterized by a pyogenic meningoencephalitis (the development of pus is called pyogenesis) and coma eventually occur [44, 45, 62]. Death occurs one week after the onset of symptoms. PAME mainly affects children and young adults. Therefore, similar to malaria, PAME can be considered a dangerous childhood disease [44, 62, 63]. However, infections with Naegleria fowleri are significantly rarer than with Plasmodium spp. About 400 cases are reported in the literature per year (381 PAM cases in 2018). Patients are usually male (75%) and have an average age of 14 years. In the US, 16 cases are reported for 2018, including 8 male and 8 female patients. All of these cases were fatal. PAME is considered extremely fatal. In the USA, of 157 documented cases between the years 1962 and 2022, only four patients survived [64–67]. N. fowleri is classified as a neglected (tropical) disease [35]. These NTDs include infectious diseases that are fatal and/or very dangerous, but not as focused on as other infectious diseases (neglected). The reason for this neglect can be manifold. For example, many neglected diseases play an important medical role in poorer countries of the global south. The health systems in these countries need to be expanded and are often dependent on donations from non-governmental organizations of development aid. As a result of this donation system, the financial resources required for research and treatment of these neglected diseases are often lacking. The lack of trained specialists is also a reason for this neglect [68]. N. fowleri is not reportable [66].

Immunity

As there is still no reliable drug therapy against N. fowleri, understanding the immune response is important for research and the development of new drugs and therapeutics. As the infection is fatal in humans, immunologists rely on animal models.

Innate Immune Response

Studies have shown that the infiltration of the amoeba cells in the nose occurs with little inflammation. This initial infiltration is in stark contrast to the aggressive inflammation that occurs later in the brain. The lethal inflammatory reaction ultimately results from the discovery and subsequent infiltration of immune cells (neutrophils, eosinophils, monocytes and macrophages) into the brain tissue [69]. The lack of an inflammatory response upon infiltration of the nasal tissue with subsequent strong reactions in the brain indicates that the amoebae have a way to bypass the innate immune response and invade the tissue undetected [70]. In contrast to bacterial and viral infections, the detection of protists by the immune system is more difficult. Since the cells of the pathogen are eukaryote just like the host cells, they are often recognized as non-foreign by the pattern recognition ability of the immune system [71]. Infections with amoebae can lead to increased activity of neutrophil granulocytes via antibody-mediated complement activation. However, studies show that N. fowleri have a certain resistance to the lysis mediated by this cascade. Only limited evidence shows that the complement system is relevant for immunology against N. fowleri [72].

In the host, N. fowleri feeds by trogocytosis, similar to how immune cells interrogate antigens from antige-presenting cells [73]. It can be assumed that this behavior puts the body cells under strong stress, which could, for example, lead to a strong release of substances like ATP [74]. However, there is little data on this approach. The situation is better when it comes to researching cytokines and their role in the immune response to N. fowleri. Tumor necrosis factor alpha (TNFα) probably plays an important role. This activates neutrophil cells, which in turn attack the amoebae. Important mechanisms of this attack are probably related to enzymes such as myeloperoxidase, superoxide formation or the release of so-called extracellular traps [75, 76]. Studies with animal models show that TNFα also plays a crucial role in the control of the disease and the development of PAM. Animals injected with TNFα did not develop PAM, even after the onset of the disease [77]. This knowledge is of particular importance for the development of new therapies. However, there are still many unanswered questions. For example, it is still unclear how the activated neutrophils detect the amoebae in the tissue and launch a coordinated attack. Individual neutrophil cells cannot tackle an N. fowleri amoeba with success [78].

Innate Immune Response

The study of the adaptive immune response to N. fowleri infections is difficult due to the rapid lethal course. Surface-binding antibodies can be rapidly taken up by N. fowleri [79]. Thus, the amoeba can undermine the humoral immune response to a certain degree. However, since antibodies to a certain degree. However, since antibodies are constantly produced in vivo, this uptake is inhibited at some point. Immunization strategies experimenting with different antigens and cell states (amoeba lysate, living amoebae, fixed amoebae, specific proteins) showed that circulating antibodies are the main immune mechanism of the adaptive immune response [79]. The intrathecal administration of therapeutic monoclonal antibodies was able to prolong the survival of animal models. Antibodies affect N. fowleri in various ways. They can opsonize the cells and thus facilitate phagocytosis or effector activity. However, many antibodies against N. fowleri are directed against internal cell structures and do not target surface proteins [80]. During acute infection, IgM is produced by the immune cells. IgM is also used in infection with N. fowleri and can trigger agglutination and complement activation. However, IgM has difficulty to cross the blood–brain barrier due to its large molecular weight (approx. 900kD) [69].

In addition to the problem of the large molecular weight, other factors can negatively influence IgM. For example, various surface antigens of amoebic cells can promote T-independent reactions. Similar reactions can also be observed with certain bacterial polysaccharides [81]. Other factors that can favour an IgM bias are defects in the Naegleria-specific CD4 + repertoire of T Cells, defects in priming and defects in the functions that facilitate antibody class switching. In general, research into the innate immune response is still incomplete. Amoeba-specific CD4 + T cell functionality has bot been carefully studied for N. fowleri either after infections or for potential vaccines [82]. And although it has been observed that cell-mediated immunity against N. fowleri is associated with a time-delayed hypersensitivity, however, the need for research is still quite high. In animal models, it has been observed that IL-4 concentration is associated with animal survival. This may be relevant for vaccination research. As this effect is strongly dependent on STAT6 (Signal Transducer and Activator of Transcription 6), it can be assumed that Th2 cells play an important role in this process. STAT6 is essential for the signalling pathway that is responsible for the formation of Th2 cells and the associated immune response [83].

Pathology and Diagnosis

In diagnostics, a fundamental distinction must be made between two temporal examinations: the premortem and the postmortem examination. The former serves the clinical diagnosis of the patient by using microscopic and molecular methods, the latter includes the autopsy and associated macroscopic examinations of the affected (brain) tissue [66].

Since the occurring symptoms are strong, but also quite unspecific. A precise diagnostic clarification is imperative. Pyogenic meningoencephalitides can have various causes, for example brain tumors or abscesses. Bacterial or viral encephalitides also cause almost identical symptoms. These conditions should be considered in the differential diagnosis. On the other hand, PAME should also be considered in cases of encephalitides that have not been further investigated (here, the travel history can also play an important role as a special part of the medical history). The diagnosis is made after microscopic and molecular examination. Molecular techniques include PCR and ELISA. There is a multiplex PCR that can be used to detect Acanthamoebae, N. fowleri and B. mandrillaris in combination [66, 84].

Macroscopy

Due to the aggressiveness and lethality of PAME, the pathological macroscopic examination can only be performed postmortem at the necropsy. This examination is primarily necessary to confirm or exclude “Naegleria fowleri/PAME” as the cause of death. The macroscopic examination is carried out by neuropathologists by examining the brain. PAME appears on the brain in the form of severe hemorrhages and associated necrosis of brain tissue. The hemorrhages are mainly localized in the frontal cortex. The Figs. 6 and 7 show an affected brain.  The tissue is typically further examined by microscopy and molecular biological methods [66].Fig. 6 Infected brain from a PAM patient. The whole brain is shown. Extensive hemorrhage and necrosis is present, mainly in the frontal cortex. ©Centers for disease control and prevention, all rights reserved

Fig. 7 Infected brain from a PAM patient. A brain section is shown. Focal hemorrhage and necrosis in frontal cortex is visible. ©Centers for disease control and prevention, all rights reserved

Microscopy and Histology

A microscopic examination is mandatory. As with other parasitic infections, it is the gold standard here and allows the detection of not only N. fowleri, but also other amoeba species. In this way, the diagnosis can be further narrowed down. Microscopic samples of the patients' cerebrospinal fluid are taken. These are obtained from the nose. A histological examination of the tissue of the Bulbus olfactorius is also permitted. The specimens can be stained. Examination after cultural cultivation is also common. Here it should be noted that the sample material is not frozen and is kept moist with a few drops of water. Otherwise, the amoebae could die. PAME is considered diagnosed when fast-moving sporozoites of N. fowleri are found. Molecular studies could confirm or further narrow down the species. A distinctive feature that can be exploited in the diagnosis of N. fowleri is its ability to differentiate cells. In hypotonic water, N. fowleri transforms into its flagellate form within two hours. This allows N. fowleri to be reliably diagnosed, as other pathogens do not have this ability [66, 85, 86] (see Figs. 8 and 9).Fig. 8 Cytospin of fixed CSF showing Giemsa-Wright stained trophozoite of Naegleria fowleri (arrow) amidst polymorphonuclear leukocytes and some lymphocytes. The nucleus and nucleolus can be seen within the trophozoite. Magnification: 1000x. ©Centers for disease control and prevention, all rights reserved

Fig. 9 A section through the cerebral portion of the brain of a PAM patient stained with hematoxylin and eosin showing large accumulations of trophozoites of Naegleria fowleri and destruction of the normal architecture of the brain tissue. Cysts are not seen. Magnification: 100x. Inset: Higher magnification (1000x) of Naegleria fowleri trophozoites (arrows) showing characteristic nuclear morphology. ©Centers for disease control and prevention, all rights reserved

Therapy

There is still no proven therapy that can be used for N. fowleri. Based on various laboratory studies and case studies, the Centers for Disease Control and Prevention recommends treatment with amphotericin B, which should be used in high doses. Amphotericin B is traditionally an antifungal agent used for severe fungal infections, but it is also used in the treatment of parasitic leishmaniasis. Amphotericin B should be administered intrathecally [66, 87–89].

Various studies examined the use of combined medications. In addition to amphotericin B, the drugs used in the studies also included fluconazole, chloramphenicol, dexamethasone, miconazole, rifampicin and miltefosine [90]. The success of the studies remained modest. A cure is very rarely. The studies showed that the effects are greatest when the drugs are administered early after exposure. The sooner the better. However, this is complicated by the rapid progression of the disease in conjunction with the diagnostic process. Another problem with the studies is that many effects have only described in vitro. Last but not least, the use in in vivo studies is ethically complex [90–92].

Miltefosine was used in some later cases [89, 93, 94]. It was shown that the success of the therapy was closely related to therapeutic temperature management (TTM) [95, 96]. The goal of TTM, also known as therapeutic hypothermia, is to lower and maintain a specific body temperature over a period of time [96]. Since N. fowleri attacks the brain, it is also important to pay attention to possible neurological damage during therapy. The effect of miltefosine on the central nervous system has also not been conclusively clarified. In 2013, a 12-year-old girl was successfully treated with miltefosine in combination with TTM. She survived the infection without neurological sequelae. However, the reason for this success was undoubtedly also the rapid diagnosis and intervention. At the same time, an 8-year-old boy was also treated with miltefosine. However, in his case TTM was omitted. He also survived, but with (probably) lifelong neurological damage. In 2016, the 12-year-old's therapy was successfully repeated in a 16-year-old male patient. This patient also survived without neurological damage. He himself simply states that learning has become more difficult for him in general [97].

In 2023, new results were published showing that treatment with benzoxaborole significantly improved life expectancy in infected mice and led to partial (28%) cure [98].

Recently, a new class of drugs and therapies has been emerging. As many anti-inflammatory agents are becoming outdated due to their sometimes severe side effects, new classes of agents are of particular interest [99]. These include the so-called anti-heterocyclic compounds. The synthesis of these active substances is accompanied by a number of advantages. Not only are they comparatively cheap to synthesize. They also have a wide range of pharmacological qualities. Studies have confirmed their antiviral, antibacterial, anticancer and insecticidal effects. Modern medical research also benefits from nanotechnology [100]. Silver nanoparticles (SNPs), for example, are of interest. In nanotechnology, materials are modified at atomic level. SNPs can be used to activate carbon composites. This is done by favourable photodeposition. This produces pure, well-defined SNPs. In addition to other uses, they play an important role as therapeutics agents. For example, as reagents and precursor for various formulations against COVID-19 or cancer. They can also be used as antioxidants [101, 102]. Novel substances such as these are also interesting for parasitology. Studies have already confirmed positive effects against malaria and other parasitic infections [103]. Drugs used against N. fowleri showed better effects when they were previously conjugated with silver nanoparticles. This was the case for nystatin and amphotericin B, but not for fluconazole. The researchers hope that this modification will enhance the effect of existing drugs to such an extent that the development of new drugs (which also involves investing a lot of money) will become at least partially obsolete [104].

It is questionable how likely the development of a vaccine against N. fowleri is. Due to the rarity of the disease, it is not the focus of profit-oriented pharmaceutical companies. Nevertheless, there are a few publications that deal with possible vaccines against the amoebae. In 2023, a research group from Mexico investigated the immunoprotected influence of two antigens. One of these antigens is the membrane protein MP2CL5 (Smp145). Both were injected intranasally into BALB/c mice. Cholera toxin (CT) served as an adjuvant. According to the study results, the antigens achieved a protection of 80–100%, respectively. In addition, a significant increase in T and B lymphocytes was observed. MP2CL5 is currently considered a promising candidate for a vaccine against N. fowleri [105]. In addition, research into N. fowleri also benefits from the new mRNA vaccines. mRNA vaccines against N. fowleri are already being discussed and in some cases have already been researched. In addition to feasibility, the location of the vaccination site is also part of these discussions. As a rule, the extremities are vaccinated: the arm or, in young children, in the leg. Intranasal vaccinations, i.e. vaccinations in the nose, have already been discussed for SARS-CoV-2 [106]. Since it is known that its tissue-specific exposure controls the immune system, intranasal vaccinations against N. fowleri are particularly interesting. After all, this is the first time the amoeba encounters the host tissue. Nevertheless, the development of a potent vaccine against N. fowleri remains questionable at the moment. Not least because of its rarity.

Outlook and Conclusion

Because of its lethal consequences and speed, PAME is a serious disease. For this reason, the diagnosis can also be very frightening and stressful for patients. In conclusion, the prevalence of N. fowleri should be considered in the context of climate change. The prevalence of the amoeba is thought to change with increasing climate and is likely to become more important [107]. This assumption is supported by existing epidemiological data. Cases have been increasing since 2000 [108]. This also shows an increasing range in the geographical area as well as in the age of the patients. Simply put, N. fowleri is occurring more frequently in the elderly people in more countries. It should also be noted that in India, for example, cases occur more frequently that are not water-related, i.e., do not result from swimming. How exactly these cases arose is still unclear [108]. However, they point out that N. fowleri poses an increasing threat as climate changes and should be considered in the context of climate change. Its status as an NTD complicates important developments (both in science and in (health) policy). This could become a problem in the near future. The right course should therefore be set quickly.

Funding

Open Access funding enabled and organized by Projekt DEAL.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Murray CJ Lopez AD Global mortality, disability, and the contribution of risk factors: global burden of disease study Lancet 1997 349 1436 1442 10.1016/S0140-6736(96)07495-8 9164317
Murray CJ, Lopez AD (1997) Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349:1436–14429164317 10.1016/S0140-6736(96)07495-8
2. Dehio C Berry C Bartenschlager R Persistent intracellular pathogens FEMS Microbiol Rev 2012 36 513 10.1111/j.1574-6976.2012.00336.x 22404271
Dehio C, Berry C, Bartenschlager R (2012) Persistent intracellular pathogens. FEMS Microbiol Rev 36:51322404271 10.1111/j.1574-6976.2012.00336.x
3. Löscher T Salzberger B Reisemedizin Internist 2014 55 245 10.1007/s00108-013-3332-6 24562762
Löscher T, Salzberger B (2014) Reisemedizin. Internist 55:24524562762 10.1007/s00108-013-3332-6
4. Adl SM Simpson AGB Farmer MA Andersen RA Anderson OR Barta JR Bowser SS Brugerolle G Fensome RA Fredericq S James TY Karpov S Kugrens P Krug J Lane CE Lewis LA Lodge J Lynn DH Mann DG McCourt RM Mendoza L Moestrup O Mozley-Standridge SE Nerad TA Shearer CA Smirnov AV Spiegel FW Taylor MFJR The new higher level classification of eukaryotes with emphasis on the taxonomy of protists J Eukaryot Microbiol 2005 52 399 451 10.1111/j.1550-7408.2005.00053.x 16248873
Adl SM, Simpson AGB, Farmer MA, Andersen RA, Anderson OR, Barta JR, Bowser SS, Brugerolle G, Fensome RA, Fredericq S, James TY, Karpov S, Kugrens P, Krug J, Lane CE, Lewis LA, Lodge J, Lynn DH, Mann DG, McCourt RM, Mendoza L, Moestrup O, Mozley-Standridge SE, Nerad TA, Shearer CA, Smirnov AV, Spiegel FW, Taylor MFJR (2005) The new higher level classification of eukaryotes with emphasis on the taxonomy of protists. J Eukaryot Microbiol 52:399–45116248873 10.1111/j.1550-7408.2005.00053.x
5. Burki F Roger AJ Brown MW Simpson AGB The new tree of eukaryotes Trends Ecol Evol 2020 35 43 55 10.1016/j.tree.2019.08.008 31606140
Burki F, Roger AJ, Brown MW, Simpson AGB (2020) The new tree of eukaryotes. Trends Ecol Evol 35:43–5531606140 10.1016/j.tree.2019.08.008
6. Bamforth SS Protist biogeography J Protozool 1981 28 2 9 10.1111/j.1550-7408.1981.tb02794.x 7019419
Bamforth SS (1981) Protist biogeography. J Protozool 28:2–97019419 10.1111/j.1550-7408.1981.tb02794.x
7. Cavalier-Smith T Early evolution of eukaryote feeding modes, cell structural diversity, and classification of the protozoan phyla Loukozoa, Sulcozoa, and Choanozoa Eur J Protistol 2013 49 115 178 10.1016/j.ejop.2012.06.001 23085100
Cavalier-Smith T (2013) Early evolution of eukaryote feeding modes, cell structural diversity, and classification of the protozoan phyla Loukozoa, Sulcozoa, and Choanozoa. Eur J Protistol 49:115–17823085100 10.1016/j.ejop.2012.06.001
8. Krüger T Engstler M Flagellar motility in eukaryotic human parasites Semin Cell Dev Biol 2015 46 113 127 10.1016/j.semcdb.2015.10.034 26523344
Krüger T, Engstler M (2015) Flagellar motility in eukaryotic human parasites. Semin Cell Dev Biol 46:113–12726523344 10.1016/j.semcdb.2015.10.034
9. Pawlowski J Burki F Untangling the phylogeny of amoeboid protists J Eukaryot Microbiol 2009 56 16 25 10.1111/j.1550-7408.2008.00379.x 19335771
Pawlowski J, Burki F (2009) Untangling the phylogeny of amoeboid protists. J Eukaryot Microbiol 56:16–2519335771 10.1111/j.1550-7408.2008.00379.x
10. Rogerson A Parvamoeba rugata n. g., n. sp., (Gymnamoebia, Thecamoebidae): an exceptionally small marine naked amoeba Eur J Protistol 1993 29 446 452 10.1016/S0932-4739(11)80407-4 23195743
Rogerson A (1993) Parvamoeba rugata n. g., n. sp., (Gymnamoebia, Thecamoebidae): an exceptionally small marine naked amoeba. Eur J Protistol 29:446–45223195743 10.1016/S0932-4739(11)80407-4
11. Gabaldón T Völcker E Torruella G On the biology, diversity and evolution of nucleariid Amoebae (Amorphea, Obazoa, Opithokonta1 Protist 2022 173 125895 10.1016/j.protis.2022.125895 35841659
Gabaldón T, Völcker E, Torruella G (2022) On the biology, diversity and evolution of nucleariid Amoebae (Amorphea, Obazoa, Opithokonta1. Protist 173:12589535841659 10.1016/j.protis.2022.125895
12. Tyml T Skulinová K Kavan J Ditrich O Kostka M Dyková I Heterolobosean amoebae from Arctic and Antarctic extremes: 18 novel strains of Allovahlkampfia, Vahlkampfia and Naegleria Eur J Protistol 2016 56 119 133 10.1016/j.ejop.2016.08.003 27643668
Tyml T, Skulinová K, Kavan J, Ditrich O, Kostka M, Dyková I (2016) Heterolobosean amoebae from Arctic and Antarctic extremes: 18 novel strains of Allovahlkampfia, Vahlkampfia and Naegleria. Eur J Protistol 56:119–13327643668 10.1016/j.ejop.2016.08.003
13. Rohr U Weber S Michel R Selenka F Wilhelm M Comparison of free-living amoebae in hot water systems of hospitals with isolates from moist sanitary areas by identifying genera and determining temperature tolerance Appl Environ Microbiol 1998 64 1822 1824 10.1128/AEM.64.5.1822-1824.1998 9572957
Rohr U, Weber S, Michel R, Selenka F, Wilhelm M (1998) Comparison of free-living amoebae in hot water systems of hospitals with isolates from moist sanitary areas by identifying genera and determining temperature tolerance. Appl Environ Microbiol 64:1822–18249572957 10.1128/AEM.64.5.1822-1824.1998
14. Gräf R Batsios P Meyer I Evolution of centrosomes and the nuclear lamina: amoebozoan assets Eur J Cell Biol 2015 94 249 256 10.1016/j.ejcb.2015.04.004 25952183
Gräf R, Batsios P, Meyer I (2015) Evolution of centrosomes and the nuclear lamina: amoebozoan assets. Eur J Cell Biol 94:249–25625952183 10.1016/j.ejcb.2015.04.004
15. Caron DA Hu SK Are we overestimating protistan diversity in nature? Trends Microbiol 2019 27 197 205 10.1016/j.tim.2018.10.009 30455081
Caron DA, Hu SK (2019) Are we overestimating protistan diversity in nature? Trends Microbiol 27:197–20530455081 10.1016/j.tim.2018.10.009
16. Lejeune M Rybicka JM Chadee K Recent discoveries in the pathogenesis and immune response toward Entamoeba histolytica Future Microbiol 2009 4 105 108 10.2217/17460913.4.1.105 19207103
Lejeune M, Rybicka JM, Chadee K (2009) Recent discoveries in the pathogenesis and immune response toward Entamoeba histolytica. Future Microbiol 4:105–10819207103 10.2217/17460913.4.1.105
17. Pantzaris N Tank V O’Meara D Chiodini P Lim F Martin V Thi AA P53 Entamoeba histolytica testing in the management of inflammatory bowel disease patients at university hospitals Leicester Gut 2022 71 A65 A65
Pantzaris N, Tank V, O’Meara D, Chiodini P, Lim F, Martin V, Thi AA (2022) P53 Entamoeba histolytica testing in the management of inflammatory bowel disease patients at university hospitals Leicester. Gut 71:A65–A65
18. Dhubyan Mohammed Zaki Z Prevalence of Entamoeba histolytica and Giardia lamblia associated with diarrhea in children referring to Ibn Al-Atheer Hospital in Mosul Iraq Arch Razi Inst 2022 77 73 79 35891729
Dhubyan Mohammed Zaki Z (2022) Prevalence of Entamoeba histolytica and Giardia lamblia associated with diarrhea in children referring to Ibn Al-Atheer Hospital in Mosul. Iraq Arch Razi Inst 77:73–7935891729
19. Clark CG Royal society of tropical medicine and hygiene meeting at Manson House, London, 19 February 1998. Amoebic disease Entamoeba dispar, an organism reborn Trans R Soc Trop Med Hyg 1998 92 361 364 10.1016/S0035-9203(98)91049-5 9850382
Clark CG (1998) Royal society of tropical medicine and hygiene meeting at Manson House, London, 19 February 1998. Amoebic disease Entamoeba dispar, an organism reborn. Trans R Soc Trop Med Hyg 92:361–3649850382 10.1016/S0035-9203(98)91049-5
20. Carrero JC Reyes-López M Serrano-Luna J Shibayama M Unzueta J León-Sicairos N de la Garza M Intestinal amoebiasis: 160 years of its first detection and still remains as a health problem in developing countries Int J Med Microbiol 2020 310 151358 10.1016/j.ijmm.2019.151358 31587966
Carrero JC, Reyes-López M, Serrano-Luna J, Shibayama M, Unzueta J, León-Sicairos N, de la Garza M (2020) Intestinal amoebiasis: 160 years of its first detection and still remains as a health problem in developing countries. Int J Med Microbiol 310:15135831587966 10.1016/j.ijmm.2019.151358
21. Quispe-Rodríguez GH Wankewicz AA Málaga Granda JL Lewis B Stockert K White AC Jr ´Entamoeba histolytica´ identified by stool microscopy from children with acute diarrhoea in Peru is not E. histolytica Trop Doct 2020 50 19 22 10.1177/0049475519881037 31600122
Quispe-Rodríguez GH, Wankewicz AA, Málaga Granda JL, Lewis B, Stockert K, White AC Jr (2020) ´Entamoeba histolytica´ identified by stool microscopy from children with acute diarrhoea in Peru is not E. histolytica. Trop Doct 50:19–2231600122 10.1177/0049475519881037
22. Stapleton F Contact lens-related corneal infection in Australia Clin Exp Optom 2020 103 408 417 10.1111/cxo.13082 32363626
Stapleton F (2020) Contact lens-related corneal infection in Australia. Clin Exp Optom 103:408–41732363626 10.1111/cxo.13082
23. Kaufman AR Tu EY Advances in the management of Acanthamoeba keratitis: a review of the literature and synthesized algorithmic approach Ocul Surf 2022 25 26 36 10.1016/j.jtos.2022.04.003 35462076
Kaufman AR, Tu EY (2022) Advances in the management of Acanthamoeba keratitis: a review of the literature and synthesized algorithmic approach. Ocul Surf 25:26–3635462076 10.1016/j.jtos.2022.04.003
24. Bao X Wiehe R Dommisch H Schaefer AS Entamoeba gingivalis causes oral inflammation and tissue destruction J Dent Res 2020 99 561 567 10.1177/0022034520901738 32023135
Bao X, Wiehe R, Dommisch H, Schaefer AS (2020) Entamoeba gingivalis causes oral inflammation and tissue destruction. J Dent Res 99:561–56732023135 10.1177/0022034520901738
25. Santos JO Roldán WH Entamoeba gingivalis and Trichomonas tenax: Protozoa parasites living in the mouth Arch Oral Biol 2023 147 105631 10.1016/j.archoralbio.2023.105631 36764082
Santos JO, Roldán WH (2023) Entamoeba gingivalis and Trichomonas tenax: Protozoa parasites living in the mouth. Arch Oral Biol 147:10563136764082 10.1016/j.archoralbio.2023.105631
26. Jeon KW Genetic and physiological interactions in the amoeba-bacteria symbiosis J Eukaryot Microbiol 2004 51 502 508 10.1111/j.1550-7408.2004.tb00277.x 15537083
Jeon KW (2004) Genetic and physiological interactions in the amoeba-bacteria symbiosis. J Eukaryot Microbiol 51:502–50815537083 10.1111/j.1550-7408.2004.tb00277.x
27. Güémez A García E Primary amoebic meningoencephalitis by Naegleria fowleri: pathogenesis and treatment Biomolecules 2021 11 1320 10.3390/biom11091320 34572533
Güémez A, García E (2021) Primary amoebic meningoencephalitis by Naegleria fowleri: pathogenesis and treatment. Biomolecules 11:132034572533 10.3390/biom11091320
28. Park JS Simpson AGB Lee WJ Cho BC Ultrastructure and phylogenetic placement within Heterolobosea of the previously unclassified, extremely halophilic heterotrophic flagellate Pleurostomum flabellatum (Ruinen 1938) Protist 2007 158 397 413 10.1016/j.protis.2007.03.004 17576098
Park JS, Simpson AGB, Lee WJ, Cho BC (2007) Ultrastructure and phylogenetic placement within Heterolobosea of the previously unclassified, extremely halophilic heterotrophic flagellate Pleurostomum flabellatum (Ruinen 1938). Protist 158:397–41317576098 10.1016/j.protis.2007.03.004
29. Pánek T Ptáčková E Čepička I Survey on diversity of marine/saline anaerobic Heterolobosea (Excavata: Discoba) with description of seven new species Int J Syst Evol Microbiol 2014 64 2280 2304 10.1099/ijs.0.063487-0 24729392
Pánek T, Ptáčková E, Čepička I (2014) Survey on diversity of marine/saline anaerobic Heterolobosea (Excavata: Discoba) with description of seven new species. Int J Syst Evol Microbiol 64:2280–230424729392 10.1099/ijs.0.063487-0
30. Peña-Diaz P Lukeš J Fe-S cluster assembly in the supergroup Excavata J Biol Inorg Chem 2018 23 521 541 10.1007/s00775-018-1556-6 29623424
Peña-Diaz P, Lukeš J (2018) Fe-S cluster assembly in the supergroup Excavata. J Biol Inorg Chem 23:521–54129623424 10.1007/s00775-018-1556-6
31. Lax G Eglit Y Eme L Bertrand EM Roger AJ Simpson AGB Hemimastigophora is a novel supra-kingdom-level lineage of eukaryotes Nature 2018 564 410 414 10.1038/s41586-018-0708-8 30429611
Lax G, Eglit Y, Eme L, Bertrand EM, Roger AJ, Simpson AGB (2018) Hemimastigophora is a novel supra-kingdom-level lineage of eukaryotes. Nature 564:410–41430429611 10.1038/s41586-018-0708-8
32. Brown MW Heiss AA Kamikawa R Inagaki Y Yabuki A Tice AK Shiratori T Ishida KI Hashimoto T Simpson AGB Roger AJ Phylogenomics places orphan protistan lineages in a novel eukaryotic super-group Genome Biol Evol 2018 10 427 433 10.1093/gbe/evy014 29360967
Brown MW, Heiss AA, Kamikawa R, Inagaki Y, Yabuki A, Tice AK, Shiratori T, Ishida KI, Hashimoto T, Simpson AGB, Roger AJ (2018) Phylogenomics places orphan protistan lineages in a novel eukaryotic super-group. Genome Biol Evol 10:427–43329360967 10.1093/gbe/evy014
33. Stahl LM Olson JB Environmental abiotic and biotic factors affecting the distribution and abundance of Naegleria fowleri FEMS Microbiol Ecol 2020 97 fiaa238 10.1093/femsec/fiaa238 33242082
Stahl LM, Olson JB (2020) Environmental abiotic and biotic factors affecting the distribution and abundance of Naegleria fowleri. FEMS Microbiol Ecol 97:fiaa23833242082 10.1093/femsec/fiaa238
34. Huizinga HW McLaughlin GL Thermal ecology of Naegleria fowleri from a power plant cooling reservoir Appl Environ Microbiol 1990 56 2200 2205 10.1128/aem.56.7.2200-2205.1990 1975164
Huizinga HW, McLaughlin GL (1990) Thermal ecology of Naegleria fowleri from a power plant cooling reservoir. Appl Environ Microbiol 56:2200–22051975164 10.1128/aem.56.7.2200-2205.1990
35. Martínez-Castillo M Cárdenas-Zúñiga R Coronado-Velázquez D Debnath A Serrano-Luna J Shibayama M Naegleria fowleri after 50 years: is it a neglected pathogen? J Med Microbiol 2016 65 885 896 10.1099/jmm.0.000303 27381464
Martínez-Castillo M, Cárdenas-Zúñiga R, Coronado-Velázquez D, Debnath A, Serrano-Luna J, Shibayama M (2016) Naegleria fowleri after 50 years: is it a neglected pathogen? J Med Microbiol 65:885–89627381464 10.1099/jmm.0.000303
36. Zhang H Cheng X Various brain-eating amoebae: the protozoa, the pathogenesis, and the disease Front Med 2021 15 842 866 10.1007/s11684-021-0865-2 34825341
Zhang H, Cheng X (2021) Various brain-eating amoebae: the protozoa, the pathogenesis, and the disease. Front Med 15:842–86634825341 10.1007/s11684-021-0865-2
37. Esterman A Roder DM Cameron AS Robinson BS Walters RP Lake JA Christy PE Determinants of the microbiological characteristics of South Australian swimming pools Appl Environ Microbiol 1984 47 325 328 10.1128/aem.47.2.325-328.1984 6424565
Esterman A, Roder DM, Cameron AS, Robinson BS, Walters RP, Lake JA, Christy PE (1984) Determinants of the microbiological characteristics of South Australian swimming pools. Appl Environ Microbiol 47:325–3286424565 10.1128/aem.47.2.325-328.1984
38. Evdokiou A Marciano-Cabral F Jamerson M Studies on the cyst stage of Naegleria fowleri in vivo and in vitro J Eukaryot Microbiol 2022 69 e12881 10.1111/jeu.12881 34918439
Evdokiou A, Marciano-Cabral F, Jamerson M (2022) Studies on the cyst stage of Naegleria fowleri in vivo and in vitro. J Eukaryot Microbiol 69:e1288134918439 10.1111/jeu.12881
39. Saygi G Naegleria gruberi—a pathogen? Lancet 1969 2 273 10.1016/S0140-6736(69)90044-0 4184136
Saygi G (1969) Naegleria gruberi—a pathogen? Lancet 2:2734184136 10.1016/S0140-6736(69)90044-0
40. Ženíšková K Grechnikova M Sutak R Copper metabolism in Naegleria gruberi and its deadly relative Naegleria fowleri Front Cell Dev Biol 2022 10 853463 10.3389/fcell.2022.853463 35478954
Ženíšková K, Grechnikova M, Sutak R (2022) Copper metabolism in Naegleria gruberi and its deadly relative Naegleria fowleri. Front Cell Dev Biol 10:85346335478954 10.3389/fcell.2022.853463
41. Fulton C Cell differentiation in Naegleria gruberi Annu Rev Microbiol 1977 31 597 629 10.1146/annurev.mi.31.100177.003121 334046
Fulton C (1977) Cell differentiation in Naegleria gruberi. Annu Rev Microbiol 31:597–629334046 10.1146/annurev.mi.31.100177.003121
42. Fritz-Laylin LK Assaf ZJ Chen S Cande WZ Naegleria gruberi de novo basal body assembly occurs via stepwise incorporation of conserved proteins Eukaryot Cell 2010 9 860 865 10.1128/EC.00381-09 20400468
Fritz-Laylin LK, Assaf ZJ, Chen S, Cande WZ (2010) Naegleria gruberi de novo basal body assembly occurs via stepwise incorporation of conserved proteins. Eukaryot Cell 9:860–86520400468 10.1128/EC.00381-09
43. Lee J De novo formation of basal bodies during cellular differentiation of Naegleria gruberi: progress and hypotheses Semin Cell Dev Biol 2010 21 156 162 10.1016/j.semcdb.2009.12.009 20035893
Lee J (2010) De novo formation of basal bodies during cellular differentiation of Naegleria gruberi: progress and hypotheses. Semin Cell Dev Biol 21:156–16220035893 10.1016/j.semcdb.2009.12.009
44. Baig AM Khan NA Tackling infection owing to brain-eating amoeba Acta Trop 2015 142 86 88 10.1016/j.actatropica.2014.11.004 25445746
Baig AM, Khan NA (2015) Tackling infection owing to brain-eating amoeba. Acta Trop 142:86–8825445746 10.1016/j.actatropica.2014.11.004
45. Harris GR Batra R Naegleria fowleri N Engl J Med 2020 383 1057 10.1056/NEJMicm2002528 32905679
Harris GR, Batra R (2020) Naegleria fowleri. N Engl J Med 383:105732905679 10.1056/NEJMicm2002528
46. Cope JR Ratard RC Hill VR Sokol T Causey JJ Yoder JS Mirani G Mull B Mukerjee KA Narayanan J Doucet M Qvarnstrom Y Poole CN Akingbola OA Ritter JM Xiong Z da Silva AJ Roellig D Van Dyke RB Stern H Xiao L Beach MJ The first association of a primary amebic meningoencephalitis death with culturable Naegleria fowleri in tap water from a US treated public drinking water system Clin Infect Dis 2015 60 e36 42 10.1093/cid/civ017 25595746
Cope JR, Ratard RC, Hill VR, Sokol T, Causey JJ, Yoder JS, Mirani G, Mull B, Mukerjee KA, Narayanan J, Doucet M, Qvarnstrom Y, Poole CN, Akingbola OA, Ritter JM, Xiong Z, da Silva AJ, Roellig D, Van Dyke RB, Stern H, Xiao L, Beach MJ (2015) The first association of a primary amebic meningoencephalitis death with culturable Naegleria fowleri in tap water from a US treated public drinking water system. Clin Infect Dis 60:e36-4225595746 10.1093/cid/civ017
47. Üstüntürk-Onan M Walochnik J Identification of free-living amoebae isolated from tap water in Istanbul, Turkey Exp Parasitol 2018 195 34 37 10.1016/j.exppara.2018.10.002 30336121
Üstüntürk-Onan M, Walochnik J (2018) Identification of free-living amoebae isolated from tap water in Istanbul, Turkey. Exp Parasitol 195:34–3730336121 10.1016/j.exppara.2018.10.002
48. Sowerby LJ Wright ED Tap water or “sterile” water for sinus irrigations: what are our patients using? Int Forum Allergy Rhinol 2012 2 300 302 10.1002/alr.21031 22411733
Sowerby LJ, Wright ED (2012) Tap water or “sterile” water for sinus irrigations: what are our patients using? Int Forum Allergy Rhinol 2:300–30222411733 10.1002/alr.21031
49. Centers for Disease Control and Prevention (CDC) Notes from the field: primary amebic meningoencephalitis associated with ritual nasal rinsing—St. Thomas, U.S. Virgin Islands, 2012 MMWR Morb Mortal Wkly Rep 2013 62 903 24226628
Centers for Disease Control and Prevention (CDC) (2013) Notes from the field: primary amebic meningoencephalitis associated with ritual nasal rinsing—St. Thomas, U.S. Virgin Islands, 2012. MMWR Morb Mortal Wkly Rep 62:90324226628
50. Authors No Primary amebic meningoencephalitis associated with ritual nasal rinsing—St Thomas, US Virgin Islands, 2012 Clin Infect Dis 2014 58 2
No authors stated (2014) Primary amebic meningoencephalitis associated with ritual nasal rinsing—St Thomas, US Virgin Islands, 2012. Clin Infect Dis 58:2
51. Levin S Goodman LJ Fuhrer J Fulminant community—acquired infectious diseases: diagnostic problems Med Clin North Am 1986 70 967 986 10.1016/S0025-7125(16)30907-5 3736273
Levin S, Goodman LJ, Fuhrer J (1986) Fulminant community—acquired infectious diseases: diagnostic problems. Med Clin North Am 70:967–9863736273 10.1016/S0025-7125(16)30907-5
52. Bernard BK, Hubbs SA (2020) Extremely rare but deadly: brain-eating Naegleria fowleri amoeba in water. Water quality and health council. https://waterandhealth.org/safe-drinking-water/drinking-water/extremely-rare-but-deadly-brain-eating-naegleria-fowleri-amoeba-in-water/. Accessed June 13, 2023
53. Masaka E Reed S Davidson M Oosthuizen J Opportunistic premise plumbing pathogens. A potential health risk in water mist systems used as a cooling intervention Pathogens 2021 10 462 10.3390/pathogens10040462 33921277
Masaka E, Reed S, Davidson M, Oosthuizen J (2021) Opportunistic premise plumbing pathogens. A potential health risk in water mist systems used as a cooling intervention. Pathogens 10:46233921277 10.3390/pathogens10040462
54. Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Foodborne, Waterborne, and Environmental Disease (DFWED) (2023) Naegleria fowleri—primary amebic meningoencephalitis (PAM)—amebic encephalitis. Centers for Disease Control and Prevention. https://www.cdc.gov/parasites/naegleria/general.html. Accessed June 13, 2023
55. Weber N (2016) Ein rätselhafter Patient: Gefahr im Pool. Der Spiegel. https://www.spiegel.de/gesundheit/diagnose/meningitis-aus-dem-swimmingpool-ein-raetselhafter-patient-a-1091873.html. Accessed June 13, 2023
56. Shute N (2011) Your health: to avoid brain-eating amoebas, hold your nose. NPR. https://www.npr.org/sections/health-shots/2011/08/19/139781956/hold-your-nose-to-avoid-brain-eating-amoebas. Accessed June 13, 2023.
57. Baig AM Primary amoebic meningoencephalitis preventive nose plugs: prophylaxis against Naegleria fowleri J Med Devices 2016 10 014501 10.1115/1.4032106
Baig AM (2016) Primary amoebic meningoencephalitis preventive nose plugs: prophylaxis against Naegleria fowleri. J Med Devices 10:01450110.1115/1.4032106
58. Kramer MH Lerner CJ Visvesvara GS Kidney and liver transplants from a donor infected with Naegleria fowleri J Clin Microbiol 1997 35 1032 1033 10.1128/jcm.35.4.1032-1033.1997 9157127
Kramer MH, Lerner CJ, Visvesvara GS (1997) Kidney and liver transplants from a donor infected with Naegleria fowleri. J Clin Microbiol 35:1032–10339157127 10.1128/jcm.35.4.1032-1033.1997
59. Roy SL Metzger R Chen JG Laham FR Martin M Kipper SW Smith LE Lyon GM 3rd Haffner J Ross JE Rye AK Johnson W Bodager D Friedman M Walsh DJ Collins C Inman B Davis BJ Robinson T Paddock C Zaki SR Kuehnert M DaSilva A Qvarnstrom Y Sriram R Visvesvara GS Risk for transmission of Naegleria fowleri from solid organ transplantation Am J Transplant 2014 14 163 171 10.1111/ajt.12536 24279908
Roy SL, Metzger R, Chen JG, Laham FR, Martin M, Kipper SW, Smith LE, Lyon GM 3rd, Haffner J, Ross JE, Rye AK, Johnson W, Bodager D, Friedman M, Walsh DJ, Collins C, Inman B, Davis BJ, Robinson T, Paddock C, Zaki SR, Kuehnert M, DaSilva A, Qvarnstrom Y, Sriram R, Visvesvara GS (2014) Risk for transmission of Naegleria fowleri from solid organ transplantation. Am J Transplant 14:163–17124279908 10.1111/ajt.12536
60. Shariq A Afridi FI Farooqi BJ Ahmed S Hussain A Fatal primary meningoencephalitis caused by Naegleria fowleri J Coll Physicians Surg Pak 2014 24 523 525 25052979
Shariq A, Afridi FI, Farooqi BJ, Ahmed S, Hussain A (2014) Fatal primary meningoencephalitis caused by Naegleria fowleri. J Coll Physicians Surg Pak 24:523–52525052979
61. Gupta R Parashar MK Kale A Primary amoebic meningoencephalitis J Assoc Physicians India 2015 63 69 71 26591176
Gupta R, Parashar MK, Kale A (2015) Primary amoebic meningoencephalitis. J Assoc Physicians India 63:69–7126591176
62. Nicholls CL Parsonson F Gray LE Heyer A Donohue S Wiseman G Norton R Primary amoebic meningoencephalitis in North Queensland: the paediatric experience Med J Aust 2016 205 325 328 10.5694/mja15.01223 27681975
Nicholls CL, Parsonson F, Gray LE, Heyer A, Donohue S, Wiseman G, Norton R (2016) Primary amoebic meningoencephalitis in North Queensland: the paediatric experience. Med J Aust 205:325–32827681975 10.5694/mja15.01223
63. Gharpure R Bliton J Goodman A Ali IKM Yoder J Cope JR Epidemiology and clinical characteristics of primary amebic meningoencephalitis caused by Naegleria fowleri: a global review Clin Infect Dis 2021 73 e19 e27 10.1093/cid/ciaa520 32369575
Gharpure R, Bliton J, Goodman A, Ali IKM, Yoder J, Cope JR (2021) Epidemiology and clinical characteristics of primary amebic meningoencephalitis caused by Naegleria fowleri: a global review. Clin Infect Dis 73:e19–e2732369575 10.1093/cid/ciaa520
64. Kemble SK Lynfield R DeVries AS Drehner DM Pomputius WF 3rd Beach MJ Visvesvara GS da Silva AJ Hill VR Yoder JS Xiao L Smith KE Danila R Fatal Naegleria fowleri infection acquired in Minnesota: possible expanded range of a deadly thermophilic organism Clin Infect Dis 2012 54 805 809 10.1093/cid/cir961 22238170
Kemble SK, Lynfield R, DeVries AS, Drehner DM, Pomputius WF 3rd, Beach MJ, Visvesvara GS, da Silva AJ, Hill VR, Yoder JS, Xiao L, Smith KE, Danila R (2012) Fatal Naegleria fowleri infection acquired in Minnesota: possible expanded range of a deadly thermophilic organism. Clin Infect Dis 54:805–80922238170 10.1093/cid/cir961
65. Capewell LG Harris AM Yoder JS Cope JR Eddy BA Roy SL Visvesvara GS Fox LM Beach MJ Diagnosis, clinical course, and treatment of primary amoebic meningoencephalitis in the United States, 1937–2013 J Pediatric Infect Dis Soc 2015 4 e68 e75 10.1093/jpids/piu103 26582886
Capewell LG, Harris AM, Yoder JS, Cope JR, Eddy BA, Roy SL, Visvesvara GS, Fox LM, Beach MJ (2015) Diagnosis, clinical course, and treatment of primary amoebic meningoencephalitis in the United States, 1937–2013. J Pediatric Infect Dis Soc 4:e68–e7526582886 10.1093/jpids/piu103
66. RKI (2015) Amöbenenzephalitis. Robert Koch-Institut. https://www.rki.de/DE/Content/Infekt/EpidBull/Merkblaetter/Ratgeber_Amoebenenzephalitis.html. Accessed June 20, 2023
67. Matanock A Mehal JM Liu L Blau DM Cope JR Estimation of undiagnosed Naegleria fowleri primary amebic meningoencephalitis, United States1 Emerg Infect Dis 2018 24 162 164 10.3201/eid2401.170545 29260676
Matanock A, Mehal JM, Liu L, Blau DM, Cope JR (2018) Estimation of undiagnosed Naegleria fowleri primary amebic meningoencephalitis, United States1. Emerg Infect Dis 24:162–16429260676 10.3201/eid2401.170545
68. Boakye-Agyemang C (2022) Why do neglected tropical diseases suffer low priority? reliefweb. https://reliefweb.int/report/world/why-do-neglected-tropical-diseases-suffer-low-priority. Accessed June 13, 2023
69. Moseman EA Battling brain-eating amoeba: enigmas surrounding immunity to Naegleria fowleri PLoS Pathog 2020 16 e1008406 10.1371/journal.ppat.1008406 32324819
Moseman EA (2020) Battling brain-eating amoeba: enigmas surrounding immunity to Naegleria fowleri. PLoS Pathog 16:e100840632324819 10.1371/journal.ppat.1008406
70. Rojas-Hernández S Jarillo-Luna A Rodríguez-Monroy M Moreno-Fierros L Campos-Rodríguez R Immunohistochemical characterization of the initial stages of Naegleria fowleri meningoencephalitis in mice Parasitol Res 2004 94 31 36 10.1007/s00436-004-1177-6 15338289
Rojas-Hernández S, Jarillo-Luna A, Rodríguez-Monroy M, Moreno-Fierros L, Campos-Rodríguez R (2004) Immunohistochemical characterization of the initial stages of Naegleria fowleri meningoencephalitis in mice. Parasitol Res 94:31–3615338289 10.1007/s00436-004-1177-6
71. Best AM Abu Kwaik Y Evasion of phagotrophic predation by protist hosts and innate immunity of metazoan hosts by Legionella pneumophila Cell Microbiol 2019 21 e12971 10.1111/cmi.12971 30370624
Best AM, Abu Kwaik Y (2019) Evasion of phagotrophic predation by protist hosts and innate immunity of metazoan hosts by Legionella pneumophila. Cell Microbiol 21:e1297130370624 10.1111/cmi.12971
72. Cervantes-Sandoval I Serrano-Luna J García-Latorre E Tsutsumi V Shibayama M Characterization of brain inflammation during primary amoebic meningoencephalitis Parasitol Int 2008 57 307 313 10.1016/j.parint.2008.01.006 18374627
Cervantes-Sandoval I, Serrano-Luna J, García-Latorre E, Tsutsumi V, Shibayama M (2008) Characterization of brain inflammation during primary amoebic meningoencephalitis. Parasitol Int 57:307–31318374627 10.1016/j.parint.2008.01.006
73. Dance A Core concept: cells nibble one another via the under-appreciated process of trogocytosis Proc Natl Acad Sci USA 2019 116 17608 17610 10.1073/pnas.1912252116 31481628
Dance A (2019) Core concept: cells nibble one another via the under-appreciated process of trogocytosis. Proc Natl Acad Sci USA 116:17608–1761031481628 10.1073/pnas.1912252116
74. Jassam YN Izzy S Whalen M Mcgavern DB El Khoury J Neuroimmunology of traumatic brain injury: time for a paradigm shift Neuron 2017 95 1246 1265 10.1016/j.neuron.2017.07.010 28910616
Jassam YN, Izzy S, Whalen M, Mcgavern DB, El Khoury J (2017) Neuroimmunology of traumatic brain injury: time for a paradigm shift. Neuron 95:1246–126528910616 10.1016/j.neuron.2017.07.010
75. Ferrante A Mocatta TJ Human neutrophils require activation by mononuclear leucocyte conditioned medium to kill the pathogenic free-living amoeba Naegleria fowleri Clin Exp Immunol 1984 56 559 566 6378454
Ferrante A, Mocatta TJ (1984) Human neutrophils require activation by mononuclear leucocyte conditioned medium to kill the pathogenic free-living amoeba, Naegleria fowleri. Clin Exp Immunol 56:559–5666378454
76. Michelson MK Henderson WR Chi EY Fritsche TR Klebanoff SJ Ultrastructural studies on the effect of tumor necrosis factor on the interaction of neutrophils and Naegleria fowleri Am J Trop Med Hyg 1990 42 225 233 10.4269/ajtmh.1990.42.225 2316792
Michelson MK, Henderson WR, Chi EY, Fritsche TR, Klebanoff SJ (1990) Ultrastructural studies on the effect of tumor necrosis factor on the interaction of neutrophils and Naegleria fowleri. Am J Trop Med Hyg 42:225–2332316792 10.4269/ajtmh.1990.42.225
77. Ferrante A Lederer E Curative properties of muramyl dipeptide in experimental Naegleria meningoencephalitis Trans R Soc Trop Med Hyg 1986 80 323 326 10.1016/0035-9203(86)90048-9 3538525
Ferrante A, Lederer E (1986) Curative properties of muramyl dipeptide in experimental Naegleria meningoencephalitis. Trans R Soc Trop Med Hyg 80:323–3263538525 10.1016/0035-9203(86)90048-9
78. Marciano-Cabral F Cabral GA The immune response to Naegleria fowleri amebae and pathogenesis of infection FEMS Immunol Med Microbiol 2007 51 243 259 10.1111/j.1574-695X.2007.00332.x 17894804
Marciano-Cabral F, Cabral GA (2007) The immune response to Naegleria fowleri amebae and pathogenesis of infection. FEMS Immunol Med Microbiol 51:243–25917894804 10.1111/j.1574-695X.2007.00332.x
79. Shibayama M Serrano-Luna J Rojas-Hernández S Campos-Rodríguez R Tsutsumi V Interaction of secretory immunoglobulin A antibodies with Naegleria fowleri trophozoites and collagen type I Can J Microbiol 2003 49 164 170 10.1139/w03-023 12795402
Shibayama M, Serrano-Luna J, Rojas-Hernández S, Campos-Rodríguez R, Tsutsumi V (2003) Interaction of secretory immunoglobulin A antibodies with Naegleria fowleri trophozoites and collagen type I. Can J Microbiol 49:164–17012795402 10.1139/w03-023
80. Reilly MF Marciano-Cabral F Bradley DW Bradley SG Agglutination of Naegleria fowleri and Naegleria gruberi by antibodies in human serum J Clin Microbiol 1983 17 576 581 10.1128/jcm.17.4.576-581.1983 6853686
Reilly MF, Marciano-Cabral F, Bradley DW, Bradley SG (1983) Agglutination of Naegleria fowleri and Naegleria gruberi by antibodies in human serum. J Clin Microbiol 17:576–5816853686 10.1128/jcm.17.4.576-581.1983
81. Cerutti A Cols M Puga I Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes Nat Rev Immunol 2013 13 118 132 10.1038/nri3383 23348416
Cerutti A, Cols M, Puga I (2013) Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol 13:118–13223348416 10.1038/nri3383
82. Lee J Yoo JK Sohn HJ Kang HK Kim D Shin HJ Kim JH Protective immunity against Naegleria fowleri infection on mice immunized with the rNfa1 protein using mucosal adjuvants Parasitol Res 2015 114 1377 1385 10.1007/s00436-015-4316-3 25604672
Lee J, Yoo JK, Sohn HJ, Kang HK, Kim D, Shin HJ, Kim JH (2015) Protective immunity against Naegleria fowleri infection on mice immunized with the rNfa1 protein using mucosal adjuvants. Parasitol Res 114:1377–138525604672 10.1007/s00436-015-4316-3
83. Carrasco-Yepez M Rojas-Hernandez S Rodriguez-Monroy M Terrazas L Moreno-Fierros L Protection against Naegleria fowleri infection in mice immunized with Cry1Ac plus amoebic lysates is dependent on the STAT6 Th2 response Parasite Immunol 2010 32 664 670 10.1111/j.1365-3024.2010.01222.x 20691018
Carrasco-Yepez M, Rojas-Hernandez S, Rodriguez-Monroy M, Terrazas L, Moreno-Fierros L (2010) Protection against Naegleria fowleri infection in mice immunized with Cry1Ac plus amoebic lysates is dependent on the STAT6 Th2 response. Parasite Immunol 32:664–67020691018 10.1111/j.1365-3024.2010.01222.x
84. Walochnik J Aspöck H Die Diagnostik von Infektionen mit freilebenden Amöben (FLA) LaboratoriumsMedizin 2005 29 446 456 10.1515/JLM.2005.061
Walochnik J, Aspöck H (2005) Die Diagnostik von Infektionen mit freilebenden Amöben (FLA). LaboratoriumsMedizin 29:446–45610.1515/JLM.2005.061
85. Kilvington S Beeching J Identification and epidemiological typing of Naegleria fowleri with DNA probes Appl Environ Microbiol 1995 61 2071 2078 10.1128/aem.61.6.2071-2078.1995 7793928
Kilvington S, Beeching J (1995) Identification and epidemiological typing of Naegleria fowleri with DNA probes. Appl Environ Microbiol 61:2071–20787793928 10.1128/aem.61.6.2071-2078.1995
86. Hamill RJ Amphotericin B formulations: a comparative review of efficacy and toxicity Drugs 2013 73 919 934 10.1007/s40265-013-0069-4 23729001
Hamill RJ (2013) Amphotericin B formulations: a comparative review of efficacy and toxicity. Drugs 73:919–93423729001 10.1007/s40265-013-0069-4
87. Kumari S Kumar V Kumar Tiwari R Ravidas V Pandey K Kumar A Amphotericin B: a drug of choice for visceral leishmaniasis Acta Trop 2022 235 106661 10.1016/j.actatropica.2022.106661 35998680
Kumari S, Kumar V, Kumar Tiwari R, Ravidas V, Pandey K, Kumar A (2022) Amphotericin B: a drug of choice for visceral leishmaniasis. Acta Trop 235:10666135998680 10.1016/j.actatropica.2022.106661
88. Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Foodborne, Waterborne, and Environmental Diseases (DFWED) (2023) Naegleria fowleri—primary Amebic meningoencephalitis (PAM)—Amebic encephalitis. Treatment. Centers for Disease Control and Prevention. https://www.cdc.gov/parasites/naegleria/treatment.html. Accessed June 20, 2023.
89. Grace E Asbill S Virga K Naegleria fowleri: pathogenesis, diagnosis, and treatment options Antimicrob Agents Chemother 2015 59 6677 6681 10.1128/AAC.01293-15 26259797
Grace E, Asbill S, Virga K (2015) Naegleria fowleri: pathogenesis, diagnosis, and treatment options. Antimicrob Agents Chemother 59:6677–668126259797 10.1128/AAC.01293-15
90. Russell AC Kyle DE Differential growth rates and In Vitro drug susceptibility to currently used drugs for multiple isolates of Naegleria fowleri Microbiol Spectr 2022 10 e0189921 10.1128/spectrum.01899-21 35138140
Russell AC, Kyle DE (2022) Differential growth rates and In Vitro drug susceptibility to currently used drugs for multiple isolates of Naegleria fowleri. Microbiol Spectr 10:e018992135138140 10.1128/spectrum.01899-21
91. Siddiqui R Mungroo MR Anuar TS Alharbi AM Alfahemi H Elmoselhi AB Khan NA Antiamoebic properties of laboratory and clinically used drugs against Naegleria fowleri and Balamuthia mandrillaris Antibiotics (Basel) 2022 11 749 10.3390/antibiotics11060749 35740156
Siddiqui R, Mungroo MR, Anuar TS, Alharbi AM, Alfahemi H, Elmoselhi AB, Khan NA (2022) Antiamoebic properties of laboratory and clinically used drugs against Naegleria fowleri and Balamuthia mandrillaris. Antibiotics (Basel) 11:74935740156 10.3390/antibiotics11060749
92. Debnath A Nelson AT Silva-Olivares A Shibayama M Siegel D McKerrow JH In vitro efficacy of Ebselen and BAY 11–7082 against Naegleria fowleri Front Microbiol 2018 9 414 10.3389/fmicb.2018.00414 29559968
Debnath A, Nelson AT, Silva-Olivares A, Shibayama M, Siegel D, McKerrow JH (2018) In vitro efficacy of Ebselen and BAY 11–7082 against Naegleria fowleri. Front Microbiol 9:41429559968 10.3389/fmicb.2018.00414
93. Rajendran K Anwar A Khan NA Shah MR Siddiqui R trans-Cinnamic acid conjugated gold nanoparticles as potent therapeutics against brain-eating amoeba Naegleria fowleri ACS Chem Neurosci 2019 10 2692 2696 10.1021/acschemneuro.9b00111 30970208
Rajendran K, Anwar A, Khan NA, Shah MR, Siddiqui R (2019) trans-Cinnamic acid conjugated gold nanoparticles as potent therapeutics against brain-eating amoeba Naegleria fowleri. ACS Chem Neurosci 10:2692–269630970208 10.1021/acschemneuro.9b00111
94. Pugh JJ Levy RA Naegleria fowleri: diagnosis, pathophysiology of brain inflammation, and antimicrobial treatments ACS Chem Neurosci 2016 7 1178 1179 10.1021/acschemneuro.6b00232 27525348
Pugh JJ, Levy RA (2016) Naegleria fowleri: diagnosis, pathophysiology of brain inflammation, and antimicrobial treatments. ACS Chem Neurosci 7:1178–117927525348 10.1021/acschemneuro.6b00232
95. Anderson CM Joseph C Fisher R Berry D Diestelhorst JB Kulstad C Wayne M Targeted temperature management using esophageal cooling Ther Hypothermia Temp Manag 2022 12 235 239 10.1089/ther.2022.0033 36301260
Anderson CM, Joseph C, Fisher R, Berry D, Diestelhorst JB, Kulstad C, Wayne M (2022) Targeted temperature management using esophageal cooling. Ther Hypothermia Temp Manag 12:235–23936301260 10.1089/ther.2022.0033
96. Kaylor HL Wiencek C Hundt E Targeted temperature management: a program evaluation AACN Adv Crit Care 2022 33 38 52 10.4037/aacnacc2022398 35259224
Kaylor HL, Wiencek C, Hundt E (2022) Targeted temperature management: a program evaluation. AACN Adv Crit Care 33:38–5235259224 10.4037/aacnacc2022398
97. Diaz J (2018) Teen who survived brain-eating amoeba says sickness gave him more outlook. SunSentinel. https://www.sun-sentinel.com/2018/07/21/teen-who-survived-brain-eating-amoeba-says-sickness-gave-him-more-positive-outlook/. Accessed Juen 20, 2023.
98. Ženíšková K Mach J Arbon D Štursa J Werner L Zoltner M Sutak R The 4-aminomethylphenoxy-benzoxaborole AN3057 as a potential treatment option for primary amoebic meningoencephalitis Antimicrob Agents Chemother 2023 67 e0150622 10.1128/aac.01506-22 36688657
Ženíšková K, Mach J, Arbon D, Štursa J, Werner L, Zoltner M, Sutak R (2023) The 4-aminomethylphenoxy-benzoxaborole AN3057 as a potential treatment option for primary amoebic meningoencephalitis. Antimicrob Agents Chemother 67:e015062236688657 10.1128/aac.01506-22
99. Sharma S Kumar D Singh G Monga V Kumar B Recent advancements in the development of heterocyclic anti-inflammatory agents Eur J Med Chem 2020 200 112438 10.1016/j.ejmech.2020.112438 32485533
Sharma S, Kumar D, Singh G, Monga V, Kumar B (2020) Recent advancements in the development of heterocyclic anti-inflammatory agents. Eur J Med Chem 200:11243832485533 10.1016/j.ejmech.2020.112438
100. Sallam ER Aboulnaga SF Samy AM Beltagy DM El Desouky JM Abdel-Hamid H Fetouh HA Synthesis, characterization of new heterocyclic compound: pyrazolyl hydrazine quinoxaline derivative: 3-[5-(hydroxy1methyl)-1-phenylpyrazol-3-yl]-2-[2, 4, 5-trimethoxybenzylidine] hydrazonyl-quinoxaline of potent antimicrobial, antioxidant, antiviral, and antitumor activity J Mol Struct 2023 1271 133983 10.1016/j.molstruc.2022.133983
Sallam ER, Aboulnaga SF, Samy AM, Beltagy DM, El Desouky JM, Abdel-Hamid H, Fetouh HA (2023) Synthesis, characterization of new heterocyclic compound: pyrazolyl hydrazine quinoxaline derivative: 3-[5-(hydroxy1methyl)-1-phenylpyrazol-3-yl]-2-[2, 4, 5-trimethoxybenzylidine] hydrazonyl-quinoxaline of potent antimicrobial, antioxidant, antiviral, and antitumor activity. J Mol Struct 1271:13398310.1016/j.molstruc.2022.133983
101. Fetouh HA Abd-Elnaby HM Alsubaie MS Sallam ER New experimental low-cost nanoscience technology for formulation of silver nanoparticles-activated carbon composite as a promising antiviral, biocide, and efficient catalyst J Exp Nanosci 2022 17 297 314 10.1080/17458080.2022.2068794
Fetouh HA, Abd-Elnaby HM, Alsubaie MS, Sallam ER (2022) New experimental low-cost nanoscience technology for formulation of silver nanoparticles-activated carbon composite as a promising antiviral, biocide, and efficient catalyst. J Exp Nanosci 17:297–31410.1080/17458080.2022.2068794
102. Almufarij RS Ali AE Elbah ME Elmaghraby NS Khashaba MA Abdel-Hamid H Fetouh HA Preparation, characterization of new antimicrobial antitumor hybrid semi-organic single crystals of proline amino acid doped by silver nanoparticles Biomedicines 2023 11 360 10.3390/biomedicines11020360 36830897
Almufarij RS, Ali AE, Elbah ME, Elmaghraby NS, Khashaba MA, Abdel-Hamid H, Fetouh HA (2023) Preparation, characterization of new antimicrobial antitumor hybrid semi-organic single crystals of proline amino acid doped by silver nanoparticles. Biomedicines 11:36036830897 10.3390/biomedicines11020360
103. Dkhil MA Abdel-Gaber R Alojaryi G Al-Shaebi EM Qasem MAA Murshed M Mares MM El-Matbouli M Al-Quraishy S Biosynthesized silver nanoparticles protect against hepatic injury induced by murine blood-stage malaria infection Environ Sci Pollut Res Int 2020 27 17762 17769 10.1007/s11356-020-08280-8 32162231
Dkhil MA, Abdel-Gaber R, Alojaryi G, Al-Shaebi EM, Qasem MAA, Murshed M, Mares MM, El-Matbouli M, Al-Quraishy S (2020) Biosynthesized silver nanoparticles protect against hepatic injury induced by murine blood-stage malaria infection. Environ Sci Pollut Res Int 27:17762–1776932162231 10.1007/s11356-020-08280-8
104. Rajendran K Anwar A Khan NA Siddiqui R Brain-eating amoebae: silver nanoparticle conjugation enhanced efficacy of anti-amoebic drugs against Naegleria fowleri ACS Chem Neurosci 2017 8 2626 2630 10.1021/acschemneuro.7b00430 29206032
Rajendran K, Anwar A, Khan NA, Siddiqui R (2017) Brain-eating amoebae: silver nanoparticle conjugation enhanced efficacy of anti-amoebic drugs against Naegleria fowleri. ACS Chem Neurosci 8:2626–263029206032 10.1021/acschemneuro.7b00430
105. Gutiérrez-Sánchez M Carrasco-Yépez MM Correa-Basurto J Ramírez-Salinas GL Rojas-Hernández S Two MP2CL5 antigen vaccines from Naegleria fowleri stimulate the immune response against meningitis in the BALB/c model Infect Immun 2023 91 e0018123 10.1128/iai.00181-23 37272791
Gutiérrez-Sánchez M, Carrasco-Yépez MM, Correa-Basurto J, Ramírez-Salinas GL, Rojas-Hernández S (2023) Two MP2CL5 antigen vaccines from Naegleria fowleri stimulate the immune response against meningitis in the BALB/c model. Infect Immun 91:e001812337272791 10.1128/iai.00181-23
106. Nouailles G Adler JM Pennitz P Peidli S Teixeira Alves LG Baumgardt M Bushe J Voss A Langenhagen A Langner C Martin Vidal R Pott F Kazmierski J Ebenig A Lange MV Mühlebach MD Goekeri C Simmons S Xing N Abdelgawad A Herwig S Cichon G Niemeyer D Drosten C Goffinet C Landthaler M Blüthgen N Wu H Witzenrath M Gruber AD Praktiknjo SD Osterrieder N Wyler E Kunec D Trimpert J Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters Nat Microbiol 2023 8 860 874 10.1038/s41564-023-01352-8 37012419
Nouailles G, Adler JM, Pennitz P, Peidli S, Teixeira Alves LG, Baumgardt M, Bushe J, Voss A, Langenhagen A, Langner C, Martin Vidal R, Pott F, Kazmierski J, Ebenig A, Lange MV, Mühlebach MD, Goekeri C, Simmons S, Xing N, Abdelgawad A, Herwig S, Cichon G, Niemeyer D, Drosten C, Goffinet C, Landthaler M, Blüthgen N, Wu H, Witzenrath M, Gruber AD, Praktiknjo SD, Osterrieder N, Wyler E, Kunec D, Trimpert J (2023) Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters. Nat Microbiol 8:860–87437012419 10.1038/s41564-023-01352-8
107. Cooper AM Aouthmany S Shah K Rega PP Killer amoebas: primary amoebic meningoencephalitis in a changing climate JAAPA 2019 32 30 35 10.1097/01.JAA.0000558238.99250.4a 31136398
Cooper AM, Aouthmany S, Shah K, Rega PP (2019) Killer amoebas: primary amoebic meningoencephalitis in a changing climate. JAAPA 32:30–3531136398 10.1097/01.JAA.0000558238.99250.4a
108. Maciver SK Piñero JE Lorenzo-Morales J Is Naegleria fowleri an emerging parasite? Trends Parasitol 2020 36 19 28 10.1016/j.pt.2019.10.008 31744676
Maciver SK, Piñero JE, Lorenzo-Morales J (2020) Is Naegleria fowleri an emerging parasite? Trends Parasitol 36:19–2831744676 10.1016/j.pt.2019.10.008
109. Goldenfeld N Pace NR Carl R Woese (1928–2012) Science 2013 339 661 10.1126/science.1235219 23393257
Goldenfeld N, Pace NR, Carl R (2013) Woese (1928–2012). Science 339:66123393257 10.1126/science.1235219
